MedTech Acquisition Co. (NASDAQ:MTAC – Get Rating) was up 0.3% during trading on Wednesday . The company traded as high as $10.40 and last traded at $10.35. Approximately 2,869 shares changed hands during trading, an increase of 78% from the average daily volume of 1,611 shares. The stock had previously closed at $10.32.
MedTech Acquisition Stock Performance
The business’s 50-day simple moving average is $10.27 and its 200 day simple moving average is $10.15.
Institutional Inflows and Outflows
A number of institutional investors and hedge funds have recently bought and sold shares of the business. Virtu Financial LLC purchased a new stake in shares of MedTech Acquisition during the fourth quarter valued at approximately $124,000. Walleye Capital LLC boosted its stake in shares of MedTech Acquisition by 14.2% during the first quarter. Walleye Capital LLC now owns 12,898 shares of the company’s stock valued at $126,000 after purchasing an additional 1,603 shares during the period. UBS Group AG boosted its stake in shares of MedTech Acquisition by 20,076.4% during the second quarter. UBS Group AG now owns 24,817 shares of the company’s stock valued at $244,000 after purchasing an additional 24,694 shares during the period. Ergoteles LLC purchased a new stake in shares of MedTech Acquisition during the first quarter valued at approximately $382,000. Finally, Centiva Capital LP boosted its stake in shares of MedTech Acquisition by 25.0% during the second quarter. Centiva Capital LP now owns 66,711 shares of the company’s stock valued at $656,000 after purchasing an additional 13,347 shares during the period. 74.91% of the stock is currently owned by institutional investors.
MedTech Acquisition Company Profile
MedTech Acquisition Corporation does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses in the healthcare sector in the United States.. The company was incorporated in 2020 and is based in Greenwich, Connecticut.
- Get a free copy of the StockNews.com research report on MedTech Acquisition (MTAC)
- Toll Brothers Rises On Results, But The Roof Is In Place
- It’s Time To Try On VF Corporation’s 6% Yield
- PetCo Management Getting it Right? Earnings Beat Says Yes
- Axcelis Stock In Buy Range After Chart Breakout, Strong Guidance
- Kohl’s 10% Yield Comes Into High Fashion
Receive News & Ratings for MedTech Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MedTech Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.